1 447

Cited 15 times in

Revised Korean medication algorithm for bipolar disorder

Authors
 DUK-IN JON  ;  WON-MYONG BAHK  ;  BO-HYUN YOON  ;  YOUNG CHUL SHIN  ;  HYUN-SANG CHO  ;  EUN LEE  ;  KYOOSEOB HA  ;  WON KIM  ;  SANG KEUN CHUNG  ;  JEONG-SEOK SEO  ;  KYUNG JOON MIN 
Citation
 WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY, Vol.10(4 pt 3) : 846-855, 2009 
Journal Title
WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
ISSN
 1562-2975 
Issue Date
2009
MeSH
Algorithms* ; Anticonvulsants/therapeutic use* ; Antidepressive Agents/therapeutic use* ; Antipsychotic Agents/therapeutic use* ; Benzodiazepines/therapeutic use ; Bipolar Disorder/drug therapy* ; Bipolar Disorder/epidemiology* ; Dibenzothiazepines/therapeutic use ; Dose-Response Relationship, Drug ; Health Personnel ; Humans ; Korea/epidemiology ; Psychiatry/statistics & numerical data ; Quetiapine Fumarate ; Risperidone/therapeutic use ; Severity of Illness Index ; Surveys and Questionnaires ; Time Factors ; Valproic Acid/therapeutic use*
Keywords
Bipolar disorder ; Korean medication algorithm ; Revision
Abstract
The rapid progress in treatments for bipolar disorder makes it necessary to revise the Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP) published in 2002. This study was performed to timely revise KMAP-BP 2002. A questionnaire comprising 37 questions and 645 treatment options was developed for surveying the opinions of Korean experts. We classified the opinions into three categories: first-, second-, and third-line treatments. Fifty-three (75.7%) of the 70 selected experts answered the questionnaire. For an acute manic episode, the combination of a mood stabilizer (MS) and an atypical antipsychotic (AAP) was the preferred first-line treatment. Most experts recommended divalproex and lithium as MSs, and olanzapine, quetiapine, and risperidone as AAPs. For moderately to severely depressed bipolar patients, MS monotherapy and a combination of an MS and an antidepressant (AD) were considered to be preferred treatments respectively. A combination of an MS and an AD was the preferred strategy in severe nonpsychotic depression. Most ADs were rated as second-line drugs. Overall, the preference for lamotrigine and AAPs was higher than in KMAP-BP 2002. The algorithm was developed mainly using consensus among experts supplemented with findings of recent clinical trials to ensure that our algorithm was both up to date and balanced. These results suggest that the medication strategies of KMAP-BP are changing rapidly, reflecting recent studies and clinical experiences.
Full Text
http://informahealthcare.com/doi/abs/10.1080/15622970802144865
DOI
10.1080/15622970802144865
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Psychiatry (정신과학교실) > 1. Journal Papers
Yonsei Authors
Lee, Eun(이은) ORCID logo https://orcid.org/0000-0002-7462-0144
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/105589
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse

Links